ProStrakan swoop on rival hastens European growth

ProStrakan chief executive Tom Stratford said the deal was a great demonstration of parent KHKs trust in the company. Picture: TSPL

TERRY MURDEN

DRUGS company ProStrakan yesterday unveiled its biggest acquisition in a move designed to help it accelerate its expansion in Europe.

The Borders-based specialty pharmaceuticals group is acquiring Archimedes Pharma for £230 million in cash provided by ProStrakan’s Japanese parent Kyowa Hakko Kirin (KHK).

The deal will boost the firm’s geographic and product footprint, particularly in treatments associated with therapeutic areas of pain, oncology and critical care. Like ProStrakan it licenses and distributes products, although it has developed PecFent, a nasal spray used by cancer patients.

The firm, based in Reading in Berkshire, has a development plant in Nottingham and operates from other sites in France, Germany and Spain. It recorded a 33 per cent rise in revenue to £41 million last year. It is a subsidiary of private limited liability company Novo, which in turn is fully owned by the Novo Nordisk Foundation.

ProStrakan chief executive Tom Stratford said: “This is very much about growth and expanding the European business. It is a great demonstration of KHK’s trust in us that it was prepared to invest a considerable sum of money to continue to grow the business.”

He described Prostrakan’s relationship with KHK as “rare” as the Galashiels company was able to continue operating as an independent business. “It is a good strategy and it is working,” he said. “The reason it has been so successful is the first-class team of people that has given KHK the confidence to invest in the business.”

The Archimedes deal, at just under six times revenue, was considered “good value” by ProStrakan’s advisers and follows two considerably smaller acquisitions since KHK bought the Scots company for £292m in 2011. The Borders firm had been listed on the stock market but had suffered manufacturing problems and delays to a key cancer-pain drug.

Archimedes helps fulfil KHK’s plans to become a global specialty pharmaceutical company. The acquisition delivers several strategic benefits to Pro- Strakan by growing its businesses in four of the largest European markets: the UK, France, Germany and Spain. In each of these countries Archimedes has sales and marketing infrastructure which will complement ProStrakan’s current operations.

The combined business sees 150 Archimedes staff added to ProStrakan’s 350, although the final details regarding any rationalisation have yet to be announced.

“Archimedes is a high-growth, high- margin business and this is a positive move for us,” said Stratford.

In 2013, ProStrakan generated a 20 per cent rise in revenue to £155m and operating profit up 138 per cent to £29.1m, or £1.6 million, after amortisation in the consolidated accouunts.

Broadening the portfolio helps position it for the launch of several products currently being developed by KHK, including one that will treat leukaemia sufferers.

Closing of the transaction is subject to anti-trust approvals in Germany.

Lazard is acting as exclusive financial advisor to KHK and ProStrakan, and Wragge Lawrence Graham & Co is acting as legal counsel to KHK and Pro-Strakan.

This website and its associated newspaper adheres to the Independent Press Standards Organisation's Editors' Code of Practice.
If you have a complaint about editorial content which relates to inaccuracy or intrusion, then contact the
Editor by clicking here.

If you remain dissatisfied with the response provided then you can contact the IPSO by
clicking here.

The Scotsman provides news, events and sport features from the Edinburgh area. For the best up to date information relating to Edinburgh and the surrounding areas visit us at The Scotsman regularly or bookmark this page.

For you to enjoy all the features of this website The Scotsman requires permission to use cookies.

Find Out More ▼

What is a Cookie?

What is a Flash Cookie?

Can I opt out of receiving Cookies?

About our Cookies

Cookies are small data files which are sent to your browser (Internet Explorer, Firefox, Chrome etc) from a website you visit. They are stored on your electronic device.

This is a type of cookie which is collected by Adobe Flash media player (it is also called a Local Shared Object) - a piece of software you may already have on your electronic device to help you watch online videos and listen to podcasts.

Yes there are a number of options available, you can set your browser either to reject all cookies, to allow only "trusted" sites to set them, or to only accept them from the site you are currently on.

However, please note - if you block/delete all cookies, some features of our websites, such as remembering your login details, or the site branding for your local newspaper may not function as a result.

The types of cookies we, our ad network and technology partners use are listed below:

Revenue Science ►

A tool used by some of our advertisers to target adverts to you based on pages you have visited in the past. To opt out of this type of targeting you can visit the 'Your Online Choices' website by clicking here.

Google Ads ►

Our sites contain advertising from Google; these use cookies to ensure you get adverts relevant to you. You can tailor the type of ads you receive by visiting here or to opt out of this type of targeting you can visit the 'Your Online Choices' website by clicking here.

Digital Analytics ►

This is used to help us identify unique visitors to our websites. This data is anonymous and we cannot use this to uniquely identify individuals and their usage of the sites.

Dart for Publishers ►

This comes from our ad serving technology and is used to track how many times you have seen a particular ad on our sites, so that you don't just see one advert but an even spread. This information is not used by us for any other type of audience recording or monitoring.

ComScore ►

ComScore monitor and externally verify our site traffic data for use within the advertising industry. Any data collected is anonymous statistical data and cannot be traced back to an individual.

Local Targeting ►

Our Classified websites (Photos, Motors, Jobs and Property Today) use cookies to ensure you get the correct local newspaper branding and content when you visit them. These cookies store no personally identifiable information.

Grapeshot ►

We use Grapeshot as a contextual targeting technology, allowing us to create custom groups of stories outside out of our usual site navigation. Grapeshot stores the categories of story you have been exposed to. Their privacy policy and opt out option can be accessed here.

Subscriptions Online ►

Our partner for Newspaper subscriptions online stores data from the forms you complete in these to increase the usability of the site and enhance user experience.

Add This ►

Add This provides the social networking widget found in many of our pages. This widget gives you the tools to bookmark our websites, blog, share, tweet and email our content to a friend.